rhodamine 123 has been researched along with orobol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Isonishi, S; Shiotsuka, S | 1 |
| Isonishi, S; Ochiai, K; Saitou, M; Tanaka, T; Yasuda, M | 1 |
2 other study(ies) available for rhodamine 123 and orobol
| Article | Year |
|---|---|
Differential sensitization by orobol in proliferating and quiescent human ovarian carcinoma cells.
Topics: 1-Phosphatidylinositol 4-Kinase; Antineoplastic Agents; Cell Cycle; Cell Survival; Cisplatin; Cystadenocarcinoma, Serous; Enzyme Inhibitors; Female; Flavonoids; Humans; Ovarian Neoplasms; Phosphatidylinositols; Rhodamine 123; Signal Transduction | 2001 |
Enhancement of sensitivity to cisplatin by orobol is associated with increased mitochondrial cytochrome c release in human ovarian carcinoma cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Caspase 3; Caspase Inhibitors; Cisplatin; Cystadenocarcinoma, Serous; Cytochrome c Group; Drug Synergism; Female; Flavonoids; Humans; Microscopy, Confocal; Microscopy, Electron; Mitochondria; Oligopeptides; Ovarian Neoplasms; Proto-Oncogene Proteins c-bcl-2; Rhodamine 123; Tumor Cells, Cultured | 2003 |